Centene's Marketplace Book Shrank 41 Percent. Its Risk-Adjustment Position Swung Favorable With It

Centene's consolidated health benefits ratio fell to 89.6% in the second quarter of 2026 from 93.0% a year earlier. GAAP net income swung to $1.1 billion from a $253 million loss, and full-year adjusted earnings guidance rose to more than $4.80 per share (Centene, July 28, 2026).

Marketplace membership fell to 3.5 million from 5.9 million over the same twelve months. A shrinking book and an improving risk-adjustment position are the same mechanism, running in the direction opposite to a year ago.

Key Takeaways

• 11.4-point swing in the Commercial health benefits ratio, to 79.2% from 90.6%, is the single largest driver of the consolidated move to 89.6% from 93.0%.
• $481 million of favorable 2025 reconciliation landed across the first half, of which roughly $250 million was already embedded in the margin estimate, leaving $180 million net, about 60 basis points of full-year margin.
• Marketplace membership fell to 3.5 million from 5.9 million in twelve months, while HHS estimates improper national enrollment fell from 5.6 million in 2025 to roughly 2.6 million for 2026.
• Roughly $0.50 of the quarter's earnings per share came from 2025 items management does not expect to recur, which matters to anyone modeling forward margin off the reported number.
• A year earlier the same process ran the other way: a $1.8 billion risk-adjustment miss worth $2.75 per share, disclosed with withdrawn guidance and a 32% premarket drop.

The Segment Numbers, and What Is Non-Recurring In Them

The consolidated 89.6% blends three segments moving at different speeds. Medicaid came in at 93.9%, improved from 94.9%, even as Centene lost more than 700,000 Medicaid members, which the company credits to states raising capitation rates toward the acuity of a post-redetermination population (Healthcare Dive, July 2026). Medicare came in at 89.5%, aided by favorable resolution of 2025 programmatic items.

Commercial, almost entirely the ACA Marketplace book, posted 79.2% against 90.6% a year earlier. An 11.4-point move inside twelve months is not what ordinary rate action produces. Rate increases move a ratio by low single digits in a year. A swing this size points to a change in the composition of who is being priced.

The dollar mechanics are layered. Centene recognized $481 million of favorable impact from the final 2025 CMS risk-adjustment reconciliation across the first half of 2026. Roughly $250 million of that was already embedded in the recurring margin estimate, and other adjustments absorbed a further slice. That leaves $180 million of net favorable development against prior guidance, worth about 60 basis points of full-year margin.

CFO Drew Asher was explicit that roughly $0.50 of the quarter's earnings per share came from 2025 items management does not expect to recur in 2027 (Drew Asher, Centene Q2 2026 earnings call, July 28, 2026). The full-year Marketplace pre-tax margin outlook moved to 4.5% to 5% from a prior 3%, leaning on both that settlement and moderating Silver-tier utilization against the elevated trend carried in first-quarter guidance.

Why a Smaller Book Produces a Higher Relative Risk Score

The membership decline is not healthy people shopping elsewhere. HHS estimates improper, phantom and fraudulent Marketplace enrollment peaked at 5.6 million people in 2025 and has been cut to roughly 2.6 million for 2026 through stepped-up income and eligibility verification. That is part of why national enrollment fell to 19.2 million by February 2026 (ASPE/HHS, June 2026).

A phantom enrollee generates essentially no claims. Removing that person does not change total claims dollars; it removes a zero-cost member from the denominator, which mechanically raises average morbidity even when no real member's health status changed. actuary.info covered the mechanics of that purge when the enrollment numbers first landed.

The transfer itself is what turns that into revenue. HHS risk adjustment is not a subsidy but a zero-sum transfer among ACA-compliant plans in the same state and market, funded by a $0.20 per-member-per-month user fee for the 2026 benefit year (CMS). CMS scores each plan's population against the statewide average and moves money from lower-scoring plans to higher-scoring ones.

A carrier's position is therefore relative, not absolute. If the removed enrollees were disproportionately low-risk, both Centene's own score and the statewide average rise, but a retained population skewing toward engaged, Silver-tier, higher-HCC-coded members can rise faster than the market it is measured against. Asher said June 2026 Wakely claims data confirmed elevated diagnoses in chronic disease, anti-inflammatory drug use and oncology categories among retained Silver membership.

The lag is structural. The final 2025 benefit-year reconciliation landed in the second quarter of 2026, more than a year after the coverage it measures was sold. That is why a risk-adjustment swing arrives as a discrete quarterly item rather than smoothing into the ratio as premium earns. That is a different funding mechanism from the Medicaid story dominating the sector's print: Molina's 92.7% Medicaid MLR rests on forward-priced state capitation catching up, which resets in the next rate cycle rather than settling backward.

Pricing 2027 Against a Book That Recomposed Twice

Insurers set 2027 Marketplace rates in filings due through the summer of 2026, before the full effect of the enrollment purge and its reconciliation was known. Early filings show statewide average increases from 6.5% in Vermont to 22.4% in Washington, driven substantially by issuers' own morbidity assumptions about who remains after subsidy-driven and program-integrity-driven attrition (Georgetown CHIR, 2026).

Some quantified it. MVP Health Plan of Vermont put continued subsidy expiration at an additional $48 per member per month of projected claims; Fallon Community Health Plan attributed 3.3 points of its 25.7% requested increase to morbidity shifts from expired enhanced premium tax credits.

Centene's own book recomposed twice inside eighteen months. The 2025 morbidity miss forced a withdrawn guidance, a $1.8 billion revenue effect and a $2.75 per-share hit (Centene, July 1, 2025; Becker's, July 2025). The 2026 purge did it again.

Pricing off a retained population's observed morbidity assumes that population is stable. Centene has disclosed it expects further attrition later in 2026 as eligibility verification continues. So the population a 2027 filing is priced against may not be the population that generates the 2027 settlement, which is not known until reconciliation lands in mid-2027.

That gap between the pricing snapshot and the settlement population is what produced the 2025 miss. It is the same Wakely-informed process reading high now that read low then, and the transfer it feeds has not become any less sensitive to enrollment volatility.